Reduction in blood pressure for people with isolated diastolic hypertension and cardiovascular outcomes. 2023

Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
Department of Cardiovascular Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Isolated diastolic hypertension (IDH) is a largely underrated risk factor for cardiovascular disease (CVD). It is currently unclear whether a reduction in blood pressure (BP) is associated with CVD events among adults with IDH. We aimed to elucidate the relationship between BP reduction and incident CVD in individuals with IDH. We retrospectively analysed the data of 71 297 individuals with IDH. Isolated diastolic hypertension was defined as systolic BP of < 140 mmHg and diastolic BP (DBP) of ≥90 mmHg (median age, 48 years; 83.1% men; median DBP, 92 mmHg). None of the participants took BP-lowering medications or had a history of CVD at baseline. Blood pressure was measured at baseline and 1-year follow-up, and participants were categorized into two groups based on DBP at 1 year (≥90 or < 90 mmHg). The primary outcome was a composite endpoint that included myocardial infarction, stroke, and all-cause death. Over a mean follow-up period of 1100 ± 859 days, 1317 composite CVD endpoints were recorded. Participants with DBP of < 90 mmHg at 1 year were at a lower risk of composite CVD events [hazard ratio (HR): 0.75, 95% confidence interval (CI): 0.67-0.83] than those with DBP of ≥90 mmHg at 1 year. A reduction in DBP per 5 mmHg during the 1-year follow-up was associated with a lower composite CVD event risk (HR: 0.92, 95% CI: 0.89-0.95). The results remained consistent across a multitude of sensitivity analyses. Our analysis of a large-scale epidemiological dataset demonstrated a relationship of reduction in DBP with a reduced risk for CVD events in individuals with IDH.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
November 2014, Current hypertension reports,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
April 2024, Journal of the American Heart Association,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
October 2019, The New England journal of medicine,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
October 2019, The New England journal of medicine,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
October 2019, The New England journal of medicine,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
January 2020, JAMA,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
October 2019, The New England journal of medicine,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
February 2017, Hypertension (Dallas, Tex. : 1979),
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
October 2014, Evidence-based medicine,
Yuta Suzuki, and Hidehiro Kaneko, and Yuichiro Yano, and Akira Okada, and Satoshi Matsuoka, and Katsuhito Fujiu, and Nobuaki Michihata, and Taisuke Jo, and Norifumi Takeda, and Hiroyuki Morita, and Koichi Node, and Hideo Yasunaga, and Issei Komuro
November 2018, International journal of cardiology,
Copied contents to your clipboard!